2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1174009849
Verify on CMS →

MANTHAN PANDYA

Endocrinology, Diabetes & Metabolism Physician in HOLMDEL, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
814
Medicare Part D claims · 185 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
47%
generic claims · 53% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75.8046/100
▼ 7 pts below national avg 83.1 · [object Object]
Industry payments
$159.26
9 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MANTHAN PANDYA reported a CMS MIPS final score of 75.8046/100 — below the 83.1 national average — and filed 814 Medicare Part D claims in 2023.

75.8046/100
MIPS score · -7 vs avg
814
Part D claims, 2023
47%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MANTHAN PANDYA's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

76 15th percentile higher than 15% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MANTHAN PANDYA practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MANTHAN PANDYA?

Below national average

NPI registry status

Active

Issued 07/16/2018

NPI 1174009849

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

814 69% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

75.8046/100 7.295400000000001% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in New Jersey

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among New Jersey providers

New Jersey providers

Endocrinology, Diabetes & Metabolism Physician share within New Jersey

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within New Jersey

Medicare quality performance — MIPS

MANTHAN PANDYA's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

Below national average
MIPS Final Score
75.8046/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 75.8046/100 vs national avg 83.1

0%100%National avg83%75.8%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 75.8046/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MANTHAN PANDYA appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider at 100 COMMONS WAY STE 140, HOLMDEL, NJ, 07733, with a listed phone of (732) 450-2925. NPI 1174009849 was issued on 07/16/2018. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PANDYA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 814 prescription claims written by this provider, covering 185 Medicare beneficiaries and totaling roughly $466K in drug spend, split 53% brand-name and 47% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75.8046/100 for the 2023 performance year (Quality 68.6551, Cost 50.6935), compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

100 COMMONS WAY STE 140
HOLMDEL, NJ 07733

Provider Details

NPI 1174009849
Specialty Endocrinology, Diabetes & Metabolism Physician
Gender Male
NPI Issued 07/16/2018

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75.8046
Final Score
Avg: 83.1
68.6551
Quality
50.6935
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MANTHAN PANDYA bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

BARNABAS HEALTH MEDICAL GROUP PC
ELIZABETH, NJ
ROBERT WOOD JOHNSON MEDICAL ASSOCIATES AT HAMILTON PA
LINDEN, NJ

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MANTHAN PANDYA. Source: openpaymentsdata.cms.gov.

Total received

$159

Largest payer

Lilly USA, LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Brand-heavy

MANTHAN PANDYA — brand share 53.0%
Specialty average (est.)

53% brand-name claims vs 47% generic, on 814 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

814
Total Claims
$466K
Total Drug Cost
185
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,927
Total Day Supply
57,113
Brand vs Generic
53% brand / 47% generic
Brand Drug Cost
$453K
Generic Drug Cost
$10K

Patient Demographics

Average Patient Age
71.9 years
Avg HCC Risk Score
1.60
Gender Split
56% female / 44% male
Age Distribution
<65: 21, 65-74: 89, 75-84: 63, 85+: 12

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MANTHAN PANDYA prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
103
Metformin Hcl
70
Ozempic
Semaglutide
53
Trulicity
Dulaglutide
29
Novolog Flexpen
Insulin Aspart
28
Januvia
Sitagliptin Phosphate
25
Jardiance
Empagliflozin
25
Glimepiride
23
Metformin Hcl Er
Metformin Hcl
21
Methimazole
21

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How MANTHAN PANDYA fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

MANTHAN PANDYA's 814 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as PANDYA.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MANTHAN PANDYA's specialty?
MANTHAN PANDYA specializes in Endocrinology, Diabetes & Metabolism Physician and practices in HOLMDEL, New Jersey.
How much does MANTHAN PANDYA prescribe under Medicare Part D?
In 2023, MANTHAN PANDYA wrote 814 Medicare Part D claims totaling $466K in drug costs for 185 beneficiaries.
What is MANTHAN PANDYA's Medicare quality score?
MANTHAN PANDYA has a CMS MIPS Final Score of 75.8046/100 (Quality: 68.6551, Cost: 50.6935). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MANTHAN PANDYA located?
MANTHAN PANDYA is located at 100 COMMONS WAY STE 140, HOLMDEL, NJ, 07733. Phone: (732) 450-2925.
What is MANTHAN PANDYA's NPI number?
MANTHAN PANDYA's National Provider Identifier (NPI) is 1174009849, issued on 07/16/2018.
Does MANTHAN PANDYA prescribe more brand-name or generic drugs?
MANTHAN PANDYA's prescribing is 53% brand-name and 47% generic drugs by claim count, with $453K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does MANTHAN PANDYA prescribe most often?
Based on 2023 Medicare Part D data, MANTHAN PANDYA's most frequently prescribed drugs include Levothyroxine Sodium, Metformin Hcl, Ozempic. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MANTHAN PANDYA accept Medicare?
MANTHAN PANDYA appears in CMS Medicare data with 814 Part D claims and 185 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MANTHAN PANDYA's credentials?
MANTHAN PANDYA's NPI is 1174009849. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology